PAM50-Based Chemo-Endocrine Score in HR-Positive HER2-Positive Breast Cancer Treated With Neoadjuvant Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Independent Validation of the PAM50-Based Chemo-Endocrine Score in Hormonal Receptor Positive HER2-Positive Breast Cancer Treated With Neoadjuvant Therapy
Clin. Cancer Res 2021 Feb 25;[EPub Ahead of Print], T Pascual, A Fernandez-Martinez, M Tanioka, MV Dieci, S Pernas, J Gavilá, V Guarneri, J Cortés, P Villagrasa, N Chic, M Vidal, B Adamo, M Muñoz, G Griguolo, A Llombart-Cussac, P Conte, M Oliveira, B Conte, L Paré, P Galván, LA Carey, CM Perou, A PratFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.